Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s...
San Francisco, unsurprisingly, has become the next American city to decriminalize psychedelics. They are following the lead of over a dozen other cities...
XPhyto Therapeutics Corp. (CSE:XPHY | OTCQB:XPHYF | FSE:4XT) is pleased to report that it has filed a patent application for a significant library of...
The Daily Hit is a recap of cannabis business news for September 19, 2022. ON THE SITE Zeroed In On Germany, Curaleaf Acquires Majority Stake in...
The article Small Pharma Completes Enrollment in Phase IIa DMT Trial was originally published on Microdose. Small Pharma has started the week with some...
The article News You Might Have Missed: Sep 19th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
In 2021, one of the leading stories for psychedelic stock investors was the introduction of ETFs focused on the burgeoning sector. Here at Psychedelic...
VANCOUVER – The Microdosing and Meditation Study, led by Beckley Foundation in collaboration with Psychedelic Data Society and Quantified Citizen (QC),...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...